Immunocore Holdings Valuation
| IMCR Stock | USD 29.81 0.62 2.04% |
At this time, the firm appears to be undervalued. Immunocore Holdings retains a regular Real Value of $37.15 per share. The prevalent price of the firm is $29.81. Our model calculates the value of Immunocore Holdings from evaluating the firm fundamentals such as Return On Asset of -0.0408, current valuation of 1.05 B, and Return On Equity of -0.14 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Immunocore Holdings' valuation include:
Price Book 3.985 | Enterprise Value | Enterprise Value Ebitda (45.82) | Price Sales 4.9115 | Enterprise Value Revenue 3.3843 |
Undervalued
Today
Please note that Immunocore Holdings' price fluctuation is very steady at this time. Calculation of the real value of Immunocore Holdings is based on 3 months time horizon. Increasing Immunocore Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Immunocore stock is determined by what a typical buyer is willing to pay for full or partial control of Immunocore Holdings. Since Immunocore Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Immunocore Stock. However, Immunocore Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 29.81 | Real 37.15 | Target 60.91 | Hype 29.77 | Naive 29.57 |
The intrinsic value of Immunocore Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Immunocore Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Immunocore Holdings helps investors to forecast how Immunocore stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Immunocore Holdings more accurately as focusing exclusively on Immunocore Holdings' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Immunocore Holdings' intrinsic value based on its ongoing forecasts of Immunocore Holdings' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Immunocore Holdings' closest peers.
Immunocore Holdings Cash |
|
Immunocore Valuation Trend
Immunocore Holdings' real value is important for investors to make better decisions and a more accurate overall view of Immunocore Holdings' financial worth over time. Using both Immunocore Holdings' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Immunocore Holdings Total Value Analysis
Immunocore Holdings is currently forecasted to have valuation of 1.05 B with market capitalization of 1.52 B, debt of 41.71 M, and cash on hands of 208.06 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Immunocore Holdings fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.05 B | 1.52 B | 41.71 M | 208.06 M |
Immunocore Holdings Investor Information
About 94.0% of the company shares are owned by institutional investors. The book value of Immunocore Holdings was currently reported as 7.21. The company recorded a loss per share of 1.02. Immunocore Holdings had not issued any dividends in recent years. Based on the key indicators related to Immunocore Holdings' liquidity, profitability, solvency, and operating efficiency, Immunocore Holdings is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Immunocore Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Immunocore Holdings has an asset utilization ratio of 30.73 percent. This connotes that the Company is making $0.31 for each dollar of assets. An increasing asset utilization means that Immunocore Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Immunocore Holdings Ownership Allocation
Immunocore Holdings has a total of 50.07 Million outstanding shares. The majority of Immunocore Holdings outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Immunocore Holdings to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Immunocore Holdings. Please pay attention to any change in the institutional holdings of Immunocore Holdings as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Immunocore Holdings Profitability Analysis
The company reported the previous year's revenue of 310.2 M. Net Loss for the year was (51.09 M) with profit before overhead, payroll, taxes, and interest of 299.7 M.About Immunocore Holdings Valuation
The stock valuation mechanism determines Immunocore Holdings' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Immunocore Holdings based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunocore Holdings. We calculate exposure to Immunocore Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Immunocore Holdings's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 307.5 M | 322.8 M | |
| Pretax Profit Margin | (0.17) | (0.18) | |
| Operating Profit Margin | (0.23) | (0.24) | |
| Net Loss | (0.16) | (0.17) | |
| Gross Profit Margin | 0.99 | 1.04 |
Immunocore Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as Immunocore Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 50 M | |
| Quarterly Earnings Growth Y O Y | 8.22 |
Immunocore Holdings Current Valuation Indicators
Immunocore Holdings' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Immunocore Holdings' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Immunocore Holdings, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Immunocore Holdings' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Immunocore Holdings' worth.Additional Tools for Immunocore Stock Analysis
When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.